$DCTH
Delcath Systems Inc

2015 Q2 Form 10-Q Financial Statement

#000156459015006231 Filed on August 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $466.0K $251.0K
YoY Change 85.66%
Cost Of Revenue $137.0K $66.00K
YoY Change 107.58% -80.0%
Gross Profit $329.0K $185.0K
YoY Change 77.84% -156.06%
Gross Profit Margin 70.6% 73.71%
Selling, General & Admin $2.502M $4.597M
YoY Change -45.57% -26.57%
% of Gross Profit 760.49% 2484.86%
Research & Development $1.450M $1.492M
YoY Change -2.82% -62.61%
% of Gross Profit 440.73% 806.49%
Depreciation & Amortization $200.0K $300.0K
YoY Change -33.33% 0.0%
% of Gross Profit 60.79% 162.16%
Operating Expenses $3.952M $6.089M
YoY Change -35.1% -40.65%
Operating Profit -$3.623M -$5.904M
YoY Change -38.63% -44.25%
Interest Expense -$50.00K $1.300M
YoY Change -103.85% -74.61%
% of Operating Profit
Other Income/Expense, Net -$28.00K $7.000K
YoY Change -500.0% -135.0%
Pretax Income -$3.700M -$4.600M
YoY Change -19.57% -16.06%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.699M -$4.600M
YoY Change -19.59% -16.06%
Net Earnings / Revenue -793.78% -1832.67%
Basic Earnings Per Share -$0.30 -$0.49
Diluted Earnings Per Share -$0.30 -$0.52
COMMON SHARES
Basic Shares Outstanding 12.24M 9.426M
Diluted Shares Outstanding 12.24M 9.481M

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.05M $27.28M
YoY Change -48.5% -15.62%
Cash & Equivalents $14.05M $27.28M
Short-Term Investments
Other Short-Term Assets $1.100M $158.0K
YoY Change 596.2% -90.06%
Inventory $280.0K $600.0K
Prepaid Expenses
Receivables $460.0K $170.0K
Other Receivables $0.00 $20.00K
Total Short-Term Assets $15.89M $28.91M
YoY Change -45.04% -17.16%
LONG-TERM ASSETS
Property, Plant & Equipment $1.500M $2.420M
YoY Change -38.02% -31.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.499M $2.420M
YoY Change -38.06% -31.05%
TOTAL ASSETS
Total Short-Term Assets $15.89M $28.91M
Total Long-Term Assets $1.499M $2.420M
Total Assets $17.39M $31.33M
YoY Change -44.5% -18.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $528.0K $240.0K
YoY Change 120.0% -66.2%
Accrued Expenses $2.060M $3.770M
YoY Change -45.36% -11.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.349M $5.400M
YoY Change -37.98% 1.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $929.0K $750.0K
YoY Change 23.87% 7400.0%
Total Long-Term Liabilities $929.0K $750.0K
YoY Change 23.87% 7400.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.349M $5.400M
Total Long-Term Liabilities $929.0K $750.0K
Total Liabilities $4.278M $6.150M
YoY Change -30.44% 14.95%
SHAREHOLDERS EQUITY
Retained Earnings -$253.7M
YoY Change
Common Stock $130.0K $95.00K
YoY Change 36.84%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K $51.00K
YoY Change 0.0%
Treasury Stock Shares $1.757K
Shareholders Equity $13.11M $25.18M
YoY Change
Total Liabilities & Shareholders Equity $17.39M $31.33M
YoY Change -44.5% -18.43%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$3.699M -$4.600M
YoY Change -19.59% -16.06%
Depreciation, Depletion And Amortization $200.0K $300.0K
YoY Change -33.33% 0.0%
Cash From Operating Activities -$4.550M -$4.000M
YoY Change 13.75% -62.12%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $20.00K
YoY Change -100.0%
Cash From Investing Activities -$40.00K $20.00K
YoY Change -300.0% -140.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 180.0K 20.00K
YoY Change 800.0% -150.0%
NET CHANGE
Cash From Operating Activities -4.550M -4.000M
Cash From Investing Activities -40.00K 20.00K
Cash From Financing Activities 180.0K 20.00K
Net Change In Cash -4.410M -3.960M
YoY Change 11.36% -62.82%
FREE CASH FLOW
Cash From Operating Activities -$4.550M -$4.000M
Capital Expenditures -$40.00K $0.00
Free Cash Flow -$4.510M -$4.000M
YoY Change 12.75% -61.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
DCTH
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
174000
CY2014Q4 us-gaap Inventory Net
InventoryNet
349000
CY2015Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
48000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-4600000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3692000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.06
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11552572
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
974000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
21966000
CY2015Q2 us-gaap Assets
Assets
17389000
CY2014Q4 us-gaap Assets
Assets
23764000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
528000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
748000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20469000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1798000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10964000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1492000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8416000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12241154
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9426169
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
us-gaap Cost Of Goods Sold
CostOfGoodsSold
160000
CY2015Q2 us-gaap Gross Profit
GrossProfit
329000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2060000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3603000
CY2015Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
761000
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
225000
CY2014Q2 us-gaap Gross Profit
GrossProfit
185000
CY2014Q4 us-gaap Liabilities
Liabilities
5619000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
910000
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
137000
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
66000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
270000
us-gaap Gross Profit
GrossProfit
640000
us-gaap Gross Profit
GrossProfit
401000
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2502000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4597000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5542000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1450000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2949000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
6089000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5904000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-3699000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-161000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1092000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4620000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000
us-gaap Net Income Loss
NetIncomeLoss
-9878000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7196000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9900000
us-gaap Operating Expenses
OperatingExpenses
11365000
us-gaap Operating Expenses
OperatingExpenses
7972000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3623000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
561000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7332000
CY2014Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1297000
us-gaap Net Income Loss
NetIncomeLoss
-7189000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7000
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253702000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
264592000
CY2015Q2 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
251000
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
266721000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1043000
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3349000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4576000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
13111000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
929000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
130000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23764000
CY2015Q2 us-gaap Liabilities
Liabilities
4278000
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
97000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
18145000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-246513000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51000
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12991707
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
13000
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17389000
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1757
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
466000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1757
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9740397
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12385016
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9708841
CY2012Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
21500000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
3952000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2430000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9363123
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12241154
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9480933
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11552572
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9462717
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
135000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
257000
us-gaap Restricted Stock Expense
RestrictedStockExpense
68000
us-gaap Restricted Stock Expense
RestrictedStockExpense
60000
us-gaap Depreciation
Depreciation
363000
us-gaap Depreciation
Depreciation
499000
us-gaap Increase Decrease In Retail Related Inventories
IncreaseDecreaseInRetailRelatedInventories
-102000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-123000
us-gaap Other Noncash Income
OtherNoncashIncome
1000
us-gaap Other Noncash Income
OtherNoncashIncome
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
126000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-856000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
285000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-183000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-59000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1712000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-110000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
383000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8957000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8485000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
22000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-85000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
22000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2656000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4521000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2656000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4521000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-30000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-23000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6416000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3965000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31249000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27284000
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
820000
dcth Fair Value Of Warrants Reclassified To Equity
FairValueOfWarrantsReclassifiedToEquity
123000
dcth Fair Value Of Warrants Reclassified To Equity
FairValueOfWarrantsReclassifiedToEquity
143000
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0625
CY2015Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
144000
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
203000
CY2015Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
114000
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
63000
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
23000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
83000
CY2015Q2 us-gaap Prepaid Insurance
PrepaidInsurance
261000
CY2014Q4 us-gaap Prepaid Insurance
PrepaidInsurance
591000
CY2015Q2 dcth Kits For Clinical Use
KitsForClinicalUse
220000
CY2014Q4 dcth Kits For Clinical Use
KitsForClinicalUse
161000
CY2015Q2 dcth Professional Fees Current
ProfessionalFeesCurrent
406000
CY2015Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
210000
CY2014Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
222000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5376000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5546000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3878000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3748000
CY2015Q2 us-gaap Depreciation
Depreciation
200000
CY2014Q2 us-gaap Depreciation
Depreciation
300000
CY2015Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1017000
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2187000
CY2015Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
171000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
341000
CY2015Q2 dcth Short Term Portion Of Lease Restructuring
ShortTermPortionOfLeaseRestructuring
209000
CY2014Q4 dcth Short Term Portion Of Lease Restructuring
ShortTermPortionOfLeaseRestructuring
239000
CY2015Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
36000
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
58000
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
627000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
778000
us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1000000
CY2012Q2 dcth Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
21100000
CY2013Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
7500000
CY2013Q4 dcth Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
6900000
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2500000
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2600000
CY2015Q1 dcth Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
2500000
CY2015Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
46000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
20000
us-gaap Share Based Compensation
ShareBasedCompensation
60000
dcth Number Of Inputs Used For Valuation Of Warrants
NumberOfInputsUsedForValuationOfWarrants
6
dcth Hypothetical Change In Market Price Of Common Shares
HypotheticalChangeInMarketPriceOfCommonShares
0.10
dcth Impact Of Hypothetical Change In Market Price Of Common Shares On Derivative Liability
ImpactOfHypotheticalChangeInMarketPriceOfCommonSharesOnDerivativeLiability
100000
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
225000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
161000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
123000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
820000
CY2015Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
761000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3081089
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1147860

Files In Submission

Name View Source Status
0001564590-15-006231-index-headers.html Edgar Link pending
0001564590-15-006231-index.html Edgar Link pending
0001564590-15-006231.txt Edgar Link pending
0001564590-15-006231-xbrl.zip Edgar Link pending
dcth-10q_20150630.htm Edgar Link pending
dcth-20150630.xml Edgar Link completed
dcth-20150630.xsd Edgar Link pending
dcth-20150630_cal.xml Edgar Link unprocessable
dcth-20150630_def.xml Edgar Link unprocessable
dcth-20150630_lab.xml Edgar Link unprocessable
dcth-20150630_pre.xml Edgar Link unprocessable
dcth-ex311_6.htm Edgar Link pending
dcth-ex312_7.htm Edgar Link pending
dcth-ex321_9.htm Edgar Link pending
dcth-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending